PAYM yields 1.89% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, PAYM + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PAYM + PFE for your $10,000?
PAYM aims to provide moderate monthly income with some downside protection, however, investors face loss of principal if the equity index falls sharply. PAYM aims to provide a lower-volatility equity strategy as compared to its sister product, PAYH. The strategy is designed to smooth returns and manage risk in changing market conditions. The ETF is actively managed, aiming to provide exposure to an autocallable index that tracks a portfolio of synthetic autocallable notes linked to a custom volatility index. The fund gains exposure to autocallable notes through total return swaps, rather than by directly holding the autocallables. Swap exposure is rebalanced or rolled weekly. Exposure to S&P 500 futures may be adjusted up to seven times daily, increasing exposure in calm markets and reducing it during volatility to stabilize risk and potentially reduce drawdowns. The fund may invest up to 25% of its assets in a Cayman Islands subsidiary for derivatives exposure.
Full PAYM Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.